Division of Pediatric Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison.
JAMA Ophthalmol. 2021 Jul 1;139(7):791-795. doi: 10.1001/jamaophthalmol.2021.1551.
Diabetic retinopathy is a major complication of diabetes for which regular screening improves visual health outcomes, yet adherence to screening is suboptimal.
To assess disparities in diabetic eye examination completion rates and evaluate barriers in those not previously screened.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort study at a single academic center (Johns Hopkins Hospital pediatric diabetes center in Baltimore, Maryland) from December 2018 to November 2019, youths with type 1 or type 2 diabetes who met criteria for diabetic retinopathy screening and were enrolled in a prospective observational trial implementing point-of-care diabetic retinopathy screening were asked about prior diabetic retinopathy screening.
Demographic and clinical characteristics were compared between those who did and did not have a previous diabetic eye examination and stratified according to race/ethnicity, using t tests and χ2 tests. Multivariate logistic regression was used to analyze the association between race/ethnicity, screening, and other social determinants of health. A questionnaire assessing barriers to screening adherence was administered.
Of 149 participants (76 male patients [51.0%]; mean [SD] age, 14.5 [2.3] years), 51 (34.2%) had not had a prior diabetic eye examination. These individuals were more likely than those who had prior diabetic eye examinations to be non-White youths (38 [75%] vs 31 [32%]; P < .001) and have type 2 diabetes (38 [75%] vs 10 [10%]; P < .001), Medicaid or public insurance (43 [84%] vs 31 [32%]; P < .001), lower household income (annual income ≤$25 000, 21 [41%] vs 9 [9%]; P < .001), and parents with education levels of high school or less (29 [67%] vs 22 [35%]; P < .001). The main barriers reported included not recalling being recommended to obtain a diabetic eye examination (19 [56%]), difficulty finding time for an additional appointment (10 [29%]), and transportation issues (7 [20%]). Minority youths were less likely to have a previous diabetic eye examination (non-White, 34 [46%] vs White, 64 [85%]; P < .001) and more likely to have diabetic retinopathy (11 [15%] v 2 [3%]; P = .008). Minority youths were less likely to get diabetic eye examinations even after adjusting for insurance, household income, and parental education level (odds ratio, 0.29 [95% CI, 0.10-0.79]; P = .02).
In this cohort study, non-White youths were less likely to undergo diabetic eye examinations yet more likely to have diabetic retinopathy compared with White youths. Addressing barriers to diabetic retinopathy screening may improve access to diabetic eye examination and facilitate early detection.
糖尿病视网膜病变是糖尿病的一种主要并发症,定期筛查可以改善视力健康结果,但对筛查的依从性并不理想。
评估糖尿病眼部检查完成率的差异,并评估以前未接受过筛查者的障碍。
设计、地点和参与者:这是一项单中心队列研究(马里兰州巴尔的摩约翰霍普金斯医院儿科糖尿病中心),于 2018 年 12 月至 2019 年 11 月进行,符合糖尿病视网膜病变筛查标准并参加了前瞻性观察性试验实施即时护理糖尿病视网膜病变筛查的 1 型或 2 型糖尿病青少年被询问了以前的糖尿病视网膜病变筛查情况。
使用 t 检验和 χ 2 检验比较了已进行和未进行既往眼部检查者的人口统计学和临床特征,并根据种族/族裔进行分层。使用多变量逻辑回归分析种族/族裔、筛查和其他健康社会决定因素之间的关联。进行了一项评估筛查依从性障碍的问卷。
在 149 名参与者(76 名男性患者[51.0%];平均[标准差]年龄 14.5[2.3]岁)中,有 51 名(34.2%)未进行过既往眼部检查。这些人与以前进行过眼部检查的人相比,更有可能是非白人青少年(38[75%]比 31[32%];P < .001)和患有 2 型糖尿病(38[75%]比 10[10%];P < .001),有医疗补助或公共保险(43[84%]比 31[32%];P < .001),家庭收入较低(年收入≤$25000,21[41%]比 9[9%];P < .001),父母教育水平较低(高中或以下,29[67%]比 22[35%];P < .001)。报告的主要障碍包括不记得被推荐进行糖尿病眼部检查(19[56%])、难以安排额外的预约时间(10[29%])和交通问题(7[20%])。少数民族青少年进行既往眼部检查的可能性较低(非白人,34[46%]比白人,64[85%];P < .001),更有可能患有糖尿病视网膜病变(11[15%]比 2[3%];P = .008)。即使在调整了保险、家庭收入和父母教育水平后,少数民族青少年接受眼部检查的可能性也较低(比值比,0.29[95%CI,0.10-0.79];P = .02)。
在这项队列研究中,与白人青少年相比,非白人青少年进行糖尿病眼部检查的可能性较低,但患有糖尿病视网膜病变的可能性较高。解决糖尿病视网膜病变筛查的障碍可能有助于改善获得糖尿病眼部检查的机会,并促进早期发现。